Bristol Myers Squibb (BMY) is investing $2.3 billion to construct a new manufacturing campus in Houston, Texas.
The campus will span 600,000 square feet.
The project will create nearly 500 permanent skilled jobs.
This project supports the company’s $40 billion commitment to U.S. research and manufacturing.
The investment is part of a broader five-year development plan.
The modular facility will produce small molecules, biologics, and antibody-drug conjugates.
The multi-modal design allows BMY to reconfigure and expand capacity to meet drug pipeline demands.
This investment aims to accelerate the delivery of next-generation medicines.